Rozanne Sandri-Goldin has forged a career that would be the envy of many scientists. Her research on the activity of herpes simplex virus genes earned her election to the prestigious American Academy of Microbiology. She recently completed a 10-year stint as editor of the Journal of Virology, the top academic publication in her field. And she’s starting a term as president of the American Society for Virology.
For sheer impact, though, it’s tough to top her latest gig: chair of a federal review committee that allocates $20 million to $30 million a year for basic research on viruses.
Leading the Virology B Study Section of the Center for Scientific Review — a division of the National Institutes of Health — may not be as exciting as discovering how a specific protein triggers recurring viral infections, but it’s integral to how U.S. science is conducted.
“The way to do research is to get funding, particularly from the NIH,” says Sandri-Goldin, professor and chair of microbiology & molecular genetics at UC Irvine’s School of Medicine. “Money from these grants not only fuels scientific discovery but provides support for thousands of graduate students, postdoctoral researchers and lab techs across the country.”
Recent Comments